Finding gene biomarkers could help diagnosis of rare and lethal cancer

In a collaboration between Arizona State University, the Biodesign Institute, and Phoenix Children's Hospital, three researchers hope to understand more about desmoplastic small round cell tumor (DSRCT). The aim is to find biomarkers and targets to help diagnose and treat this cancer, which mostly affects boys and young adults. Less than a fifth of patients will survive for more than 5 years after diagnosis. Hyundai Hope on Wheels is funding the project with $250,000 over three years, and the researchers will start with next-generation sequencing of tumor samples, followed by bioinformatic analysis. Press release

Suggested Articles

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.

Cybernet Manufacturing, maker of medical-grade computer monitors, has unveiled a new, large touchscreen designed to protect against infections.

A startup has raised $12 million to fund its real-time system for monitoring patients undergoing dialysis at home and calling in complications.